This was achieved by sequence-specific recognition and EIS analysis to detect tumor-associated mutations (PIK3CA exon 9 mutations); the biosensor modified by dCas9–sgRNA is shown in Figure 9. The gene discussed is PIK3CA; the disease is neoplasm.